Maravai LifeSciences Holdings, Inc. (MRVI) vs First Tracks Biotherapeutics, Inc. (TRAX)

Maravai LifeSciences Holdings, Inc. and First Tracks Biotherapeutics, Inc. are both Biotechnology companies. Maravai LifeSciences Holdings, Inc. and First Tracks Biotherapeutics, Inc. are of similar size ($1.9B and $1.8B). First Tracks Biotherapeutics, Inc. has the higher net margin (0.00% vs −30.8%) and the higher return on invested capital (0.00% vs −13.6%). Across the 11 metrics below, First Tracks Biotherapeutics, Inc. leads on 8 and Maravai LifeSciences Holdings, Inc. on 3.

Valuation

Metric MRVI TRAX Biotechnology median
P/E n/m n/m 10.60
P/S 5.26 n/m 9.40
P/B 3.30 11.31 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 5.75 n/m 9.02
Earnings yield (5.72%) (10.82%) (32.88%)
Free cash flow yield (1.12%) (6.57%) (23.13%)

Profitability

Metric MRVI TRAX Biotechnology median
Gross margin 39.15% — 68.51%
Operating margin (45.38%) 0.00% 0.00%
Net margin (30.83%) 0.00% 0.00%
Free cash flow margin (5.89%) 0.00% 0.00%
Return on equity (17.01%) 0.00% (51.96%)
Return on assets (9.06%) 0.00% (46.06%)
Return on invested capital (13.62%) 0.00% 0.00%

Growth

Metric MRVI TRAX Biotechnology median
Revenue growth (TTM) 10.68% — 6.76%
EPS growth (last fiscal year) 14.29% — 29.88%
Revenue growth, 5-year CAGR (8.15%) — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric MRVI TRAX Biotechnology median
Debt to equity 0.52 0.00 0.00
Current ratio 4.66 9.16 4.97
Net debt to EBITDA (0.69) — 1.01

Dividend

Metric MRVI TRAX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MRVI TRAX Biotechnology median
Market cap 1.81b 1.91b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack